Addex Therapeutics Ltd (SWX:ADXN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
0.0434
-0.0026 (-5.65%)
Jun 22, 2026, 5:31 PM CET

Addex Therapeutics Balance Sheet

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1.643.343.876.9620.48
Cash & Short-Term Investments
1.643.343.876.9620.48
Cash Growth
-50.97%-13.55%-44.44%-66.04%9.57%
Receivables
0.020.020.150.60.32
Prepaid Expenses
0.020.170.220.271.12
Other Current Assets
0.010.01000.02
Total Current Assets
1.683.544.237.8321.94
Property, Plant & Equipment
0.030.040.350.40.54
Long-Term Investments
4.137.09---
Other Long-Term Assets
0.520.010.050.050.06
Total Assets
6.3610.684.648.2822.54
Accounts Payable
0.60.250.981.281.79
Accrued Expenses
0.590.541.41.722.06
Current Portion of Leases
0.010.010.270.290.29
Current Unearned Revenue
--0.23--
Total Current Liabilities
1.20.82.893.284.13
Long-Term Leases
0.030.030.070.090.19
Long-Term Unearned Revenue
--0.09--
Pension & Post-Retirement Benefits
0.370.160.44-1.28
Total Liabilities
1.613.53.375.61
Common Stock
2.191.841.841.1549.27
Additional Paid-In Capital
267.31266.38266.19269.51283.98
Retained Earnings
-360.09-353.36-360.42-349.86-329.06
Treasury Stock
-1.01-0.87-0.91-6.28-11.7
Comprehensive Income & Other
96.3895.6894.4490.3924.44
Shareholders' Equity
4.779.681.154.9116.93
Total Liabilities & Equity
6.3610.684.648.2822.54
Total Debt
0.030.040.340.370.48
Net Cash (Debt)
1.63.33.526.5820
Net Cash Growth
-51.39%-6.29%-46.52%-67.08%10.34%
Net Cash Per Share
0.010.030.050.150.59
Filing Date Shares Outstanding
147.8398.34128.2680.8837.9
Total Common Shares Outstanding
147.8398.34125.277.1337.9
Working Capital
0.482.741.344.5517.81
Book Value Per Share
0.030.100.010.060.45
Tangible Book Value
4.779.681.154.9116.93
Tangible Book Value Per Share
0.030.100.010.060.45
Machinery
00.081.731.721.72